Hulluna Amerikassa kirjallisuus Katzenelbogenista eteenpäin
Katzenelbogen, Solomon (1940). A Critical Appraisal of the "Shock Therapies" in the Major Psychoses, II – Insulin. Psychiatry, Volume 3, Issue 2, elokuu 1940: 221–228
https://www.proquest.com/openview/fe6e4eecaac1b591c24f8d17749f8f15/1?pq-origsite=gscholar&cbl=18...
Katzenelbogen, Solomon (1940). A Critical Appraisal of the Shock Therapies in the Major Psychoses and Psychoneuroses, III – Convulsive Therapy. Psychiatry 3, elokuu 1940: 409–420
https://www.tandfonline.com/doi/pdf/10.1080/00332747.1940.11022294
https://doi.org/10.1080/00332747.1940.11022294
Keck, P. E., Jr & Cohen, B. M. & Baldessarini, R. J. & McElroy, S. L. (1989). Time course of antipsychotic effects of neuroleptic drugs. The American journal of psychiatry, Volume 146, Issue 10, lokakuu 1989: 1289–1292 https://doi.org/10.1176/ajp.146.10.1289
https://pubmed.ncbi.nlm.nih.gov/2571305/
https://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.146.10.1289
Keefe, Richard S. E. & Bollini, Anna M. & Silva, Susan G. (1999). Do Novel Antipsychotics Improve Cognition? A Report of a Meta-Analysis. Psychiatric Annals 29(11), marraskuu 1999: 623–629
Kendell, R. E. & Cooper, J. E. & Gourlay, A. J. & Copeland, J. R. & Sharpe, L., & Gurland, B. J. (1971). Diagnostic criteria of American and British psychiatrists. Archives of general psychiatry, 25(2), 123–130. https://doi.org/10.1001/archpsyc.1971.01750140027006
https://pubmed.ncbi.nlm.nih.gov/5569450/
Kennedy, N. J., & Sanborn, J. S. (1992). Disclosure of tardive dyskinesia: effect of written policy on risk disclosure. Psychopharmacology bulletin, 28(1), 1992: 93–100
https://pubmed.ncbi.nlm.nih.gov/1351688/
Kepler, Edwin J. & Moersch, Frederick P. (1937). The Psychiatric Manifestations of Hypoglycemia. American Journal of Psychiatry, Volume 94, Issue 1, heinäkuu 1937: 89–110
https://doi.org/10.1176/ajp.94.1.89
https://ajp.psychiatryonline.org/doi/10.1176/ajp.94.1.89
Kevles, Daniel J. (1985). In the Name of Eugenics: Genetics and the Uses of Human Heredity. New York: Alfred A. Knopf.
Kinon, B. J. & Kane, J. M. & Johns, C. & Perovich, R. & Ismi, M. & Koreen, A. & Weiden, P. (1993). Treatment of neuroleptic-resistant schizophrenic relapse. Psychopharmacology bulletin, 29(2), 309–314
https://pubmed.ncbi.nlm.nih.gov/7904762/
Kleinman, A. (2002). Psychiatry on the Couch [Review of The Unbalanced Mind; Creating Mental Illness; Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill; Out of Its Mind: Psychiatry in Crisis. A Call for Reform, by J. Leff, A. V. Horwitz, R. Whitaker, J. A. Hobson, & J. A. Leonard]. American Scientist, 90(6), 569–570. http://www.jstor.org/stable/27857761
https://www.americanscientist.org/article/psychiatry-on-the-couch
Kline, Nathan S. (1960). Psychopharmaceuticals: uses and abuses. Postgraduate medicine, 27, toukokuu 1960: 620–629
https://doi.org/10.1080/00325481.1960.11712918
https://pubmed.ncbi.nlm.nih.gov/14409890/
https://www.tandfonline.com/doi/pdf/10.1080/00325481.1960.11712918
Kline, Nathan S. (1968). On the rarity of "irreversible" oral dyskinesias following phenothiazines. The American Journal of Psychiatry, Volume 124, Issue 8 SUPPL, helmikuu 1968: 48–54
https://doi.org/10.1176/ajp.124.8S.48
https://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.124.8S.48
Knable, Michael B. & Heinz, Andreas & Raedler, Thomas & Weinberger, Daniel R. (1997). Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels. Psychiatry research, Volume 75, Issue 2, 29. syyskuuta 1997: 91–101
https://doi.org/10.1016/s0925-4927(97)00023-1
https://pubmed.ncbi.nlm.nih.gov/9351491/
https://www.sciencedirect.com/science/article/abs/pii/S0925492797000231?via%3Dihub
Kornhuber, J. & Riederer, P. & Reynolds, G. P. & Beckmann, H. & Jellinger, K. & Gabriel, E. (1989). 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. Journal of neural transmission, Volume 75, Issue 1, helmikuu 1989: 1–10
https://doi.org/10.1007/BF01250639
https://link.springer.com/article/10.1007/BF01250639
https://pubmed.ncbi.nlm.nih.gov/2563750/
Kraepelin, Emil (1962). One Hundred Years of Psychiatry. New York City: Philosophical Library.
https://archive.org/details/onehundredyearso011002mbp
https://www.bookyards.com/en/author/page/5320/Kraepelin-Emil#
Krystal, John H. & Seibyl, John P. & Price, Lawrence H., Woods, Scott W. & Heninger, George R., Aghajanian, George K., & Charney, Dennis S. (1993). m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Archives of general psychiatry, 50(8), elokuu 1993: 624–635
https://doi.org/10.1001/archpsyc.1993.01820200034004
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/496293
https://pubmed.ncbi.nlm.nih.gov/8102048/
Kühl, Stefan (1994). The Nazi Connection: Eugenics, American Racism, and German National Socialism. New York and Oxford: Oxford University Press.
Kutchins, Herb & Kirk, Stuart (1997). Making Us Crazy – DSM: the psychiatric bible and the creation of mental disorders. New York: Free Press
https://archive.org/details/makinguscrazydsm0000kutc/page/n3/mode/2up
Kwalwasser, Simon (1940). Report on 441 Cases Treated with Metrazol. Psychiatric Quarterly, Volume 14, syyyskuu 1940: 527–546
https://link.springer.com/article/10.1007/BF01573135
Lahti, Adrienne C. & Koffel, Bettylou & LaPorte, David & Tamminga, Carol A. (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 13(1), elokuu 1995: 9–19
https://doi.org/10.1016/0893-133X(94)00131-I
https://pubmed.ncbi.nlm.nih.gov/8526975/
https://www.nature.com/articles/1380271
Larsen, E. B., & Gerlach, J. (1996). Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics. Acta Psychiatrica Scandinavica, 93(5), 381–388. https://doi.org/10.1111/j.1600-0447.1996.tb10664.x
https://pubmed.ncbi.nlm.nih.gov/8792909/
Laughlin, Harry Hamilton (1914). BULLETIN No. 10B: Report of the Committee to Study and to Report on the Best Practical Means of Cutting Off the Defective Germ-Plasm in the American Population. II. The Legal, Legislative, and Administrative Aspects of Sterilization. New York: Eugenics Record Office.
https://repository.library.georgetown.edu/handle/10822/556986
Laughlin, Harry Hamilton. (1914). ’The Legal, Legislative, and Administrative Aspects of Sterilization’. Bulletin No. 10B: Report of the Committee to Study and to Report on the Best Practical Means of Cutting Off the Defective Germ-Plasm in the American Population. Cold Spring Harbor, New York: Eugenics Record Office.
https://repository.library.georgetown.edu/handle/10822/556986
Laughlin, Harry Hamilton (1929). The progress of American eugenics. Eugenics, 2 (2).
Laurence, William L. (1937). Mind Is 'Mapped' in Cure of Insane; Dr. Sakel Charts 'Pathways' in Those Emerging From Darkness by Aid of Insulin. New York Times 15.5.1937;
Lee, Tyrone & Seeman, Philip & Tourtellotte, W. W. & Farley, Irene J., & Hornykeiwicz, Oleh (1978). Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature, 274(5674), elokuu 1978: 897–900 https://doi.org/10.1038/274897a0
https://www.nature.com/articles/274897a0
https://pubmed.ncbi.nlm.nih.gov/683328/
Leff, J. & Sartorius, N. & Jablensky, A. & Korten, A. & Ernberg, G. (1992). The International Pilot Study of Schizophrenia: five-year follow-up findings. Psychological medicine, 22(1), helmikuu 1992: 131–145 https://doi.org/10.1017/s0033291700032797. PMID: 1574549
https://pubmed.ncbi.nlm.nih.gov/1574549/
Lehman, Anthony F. & Steinwachs, Donald M. (1998). Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophrenia bulletin, Volume 24, Issue 1, 1998: 11–32
https://doi.org/10.1093/oxfordjournals.schbul.a033303
https://pubmed.ncbi.nlm.nih.gov/9502543/
https://academic.oup.com/schizophreniabulletin/article/24/1/11/1877869
Lehmann, H. E. (1955). Therapeutic results with chlorpromazine (largactil) in psychiatric conditions. Canadian Medical Association journal, 72(2), tammikuu 1955: 91–99
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1825483/
https://pubmed.ncbi.nlm.nih.gov/13230993/
Lehmann, H. E. (1956). Neurophysiologic activity of chlorpromazine in clinical use. Journal of clinical and experimental psychopathology, 17(2), huhti-kesäkuu 1956: 129–141
https://pubmed.ncbi.nlm.nih.gov/13345875/
Lehmann H. E. (1969). Discussion: a renaissance of psychiatric diagnosis?. The American journal of psychiatry, 10 Suppl, 43–46
https://doi.org/10.1176/ajp.125.10s.43
https://pubmed.ncbi.nlm.nih.gov/5774705/
Lehmann, H.E. (1970). The Philosophy of Long-Acting Medication in Psychiatry. Diseases of the Nervous System, 31(9), liite, syykuu 1970: 7–9. Artikkeli ei löytynyt Google-haulla 7.7.2024, viitteitä siihen löytyi.
Lehmann, H. E. & Hanrahan, G. E. (1954). Chlorpromazine; new inhibiting agent for psychomotor excitement and manic states. A.M.A. archives of neurology and psychiatry, 71(2), helmikuu 1954: 227–237, doi:10.1001/archneurpsyc.1954.02320380093011
https://pubmed.ncbi.nlm.nih.gov/13123588/
https://jamanetwork.com/journals/archneurpsyc/article-abstract/651712
Lehrman, Nathaniel S. (1960). A state hospital population five years after admission: A yardstick for evaluative comparison of follow-up studies. Psychiatric Quarterly 34, 658–681 (1960). https://doi.org/10.1007/BF01562582
Lehtinen, V. & Aaltonen, J. & Koffert, T. & Räkköläinen, V. & Syvälahti, E. (2000). Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?. European psychiatry: the journal of the Association of European Psychiatrists, 15(5), 312–320
https://doi.org/10.1016/s0924-9338(00)00400-4
https://pubmed.ncbi.nlm.nih.gov/10954876/
Levy, Norman A & Grinker, Roy R. (1943). Psychological Observations in Affective Psychoses Treated with Combined Convulsive Shock and Psychotherapy. The Journal of Nervous and Mental Disease, 97(6), kesäkuu 1943: 623–637
Lewander T. (1994). Neuroleptics and the neuroleptic-induced deficit syndrome. Acta psychiatrica Scandinavica. Supplementum, 380, toukokuu 1994: 8–13
https://doi.org/10.1111/j.1600-0447.1994.tb05825.x
https://pubmed.ncbi.nlm.nih.gov/7914056/
https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.1994.tb05825.x
Lewis, Nolan D. (1943). The Present Status of Shock Therapy of Mental Disorders. Bulletin of the New York Academy of Medicine, 19(4), 227–244
https://pubmed.ncbi.nlm.nih.gov/19312314/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1933950/
Lieberman, Jeffrey A. (2002). Good Intentions Could Be Disastrous. Chapell Hill (North Carolina) News, 29. toukokuuta 2002. Artikkeli ei löytynyt Google-haulla 16.2.2024.
Lieberman, Jeffrey A. (2006). Comparative Effectiveness of Antipsychotic DrugsA Commentary on Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). Arch Gen Psychiatry, 63(10), lokakuu 2006: 1069-1072 doi:10.1001/archpsyc.63.10.1069
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/209841
Lieberman, Jeffrey A. & Jody, Darlene & Alvir, Jose Ma. J. & Ashtari, Manzar & Levy, Deborah L. & Bogerts, Bernhard & Degreef, Gustav & Mayerhoff, David I. & Cooper, Thomas (1993). Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates. Archives of general psychiatry, 50(5), toukokuu 1993: 357–368
https://doi.org/10.1001/archpsyc.1993.01820170035005
https://pubmed.ncbi.nlm.nih.gov/8489325/
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/496177
Lieberman, Jeffrey A. & Jody, Darlene & Geisler, Stephen & Alvir, Jose & Loebel, Antony & Szymanski, Sally & Woerner, Margaret & Borenstein, Michael (1993). Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of general psychiatry, 50(5), toukokuu 1993: 369–376
https://doi.org/10.1001/archpsyc.1993.01820170047006
https://pubmed.ncbi.nlm.nih.gov/8098203/
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/496181
Lieberman, J. A. & Stroup, T. S. & McEvoy, J. P. & Swartz, M. S. & Rosenheck, R. A. & Perkins, D. O. & Keefe, R. S. & Davis, S. M. & Davis, C. E. & Lebowitz, B. D. & Severe, J. & Hsiao, J. K. & Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England journal of medicine, Vol. 353, No. 12, syyskuu 2005: 1209–1223
https://doi.org/10.1056/NEJMoa051688
https://pubmed.ncbi.nlm.nih.gov/16172203/
https://www.nejm.org/doi/full/10.1056/NEJMoa051688
Lifton, Robert Jay (1986). The Nazi Doctors: Medical Killing and the Psychology of Genocide. New York: Basic Books
Lima, Almeida (1973). Egas Moniz 1887–1955. Surgical Neurology, 1(5), 1973): 247–248
https://pubmed.ncbi.nlm.nih.gov/4579684/
Lipton, A. A., & Simon, F. S. (1985). Psychiatric diagnosis in a state hospital: Manhattan state revisited. Hospital & community psychiatry, 36(4), 368–373
https://doi.org/10.1176/ps.36.4.368
https://pubmed.ncbi.nlm.nih.gov/3997096/
Loring, Marti & Powell, Brian (1988). Gender, race, and DSM-III: a study of the objectivity of psychiatric diagnostic behavior. Journal of health and social behavior, Volume 29, No 1, maaliskuu 1988: 1–22
https://www.jstor.org/stable/2137177
https://pubmed.ncbi.nlm.nih.gov/3367027/
Los Angeles Times, Roan, Shari (1996). Lives Recovered. The Los Angeles Times 30.1.1996.
https://www.latimes.com/archives/la-xpm-1996-01-30-ls-30306-story.html
Lowinger, Louis & Huddleson, James H. (1946). Complications in Electric Shock Therapy. American Journal of Psychiatry, Volume 102, Issue 5, maaliskuu 1946: 594–598
https://ajp.psychiatryonline.org/doi/10.1176/ajp.102.5.594
Luby, Elliot D. & Gottlieb, Jacques S. & Cohen, Bertram D. & Rosenbaum, Gerald & Domino, Edward F. (1962). Model psychoses and schizophrenia. The American journal of psychiatry, Volume 119, Issue 1, heinäkuu 1962: 61–67
https://doi.org/10.1176/ajp.119.1.61
https://pubmed.ncbi.nlm.nih.gov/14467063/
https://www.researchgate.net/publication/9121410_Model_psychoses_and_schizophrenia
https://psychiatryonline.org/doi/abs/10.1176/ajp.119.1.61
Lucas, P. B. & Gardner, D. L. & Wolkowitz, O. M, & Cowdry, R. W. (1987). Dysphoria associated with methylphenidate infusion in borderline personality disorder. The American journal of psychiatry, Volume 144, Issue 12, joulukuu 1987: 1577–1579
https://doi.org/10.1176/ajp.144.12.1577
https://pubmed.ncbi.nlm.nih.gov/3688282/
https://psychiatryonline.org/doi/abs/10.1176/ajp.144.12.1577
Lyerly, James G. (1938). Prefrontal Lobotomy in Involutional Melancholia. The Journal of the Florida Medical Association, Volume 25, Issue 5, marraskuu 1938: 225–229
https://archive.org/details/sim_journal-of-the-florida-medical-association_1938-11_25_5
Mabon, William & Babcock, Warren L. (1899). Thyroid Extract – A Review of the Results Obtained in the Treatment of One Thousand Thirty-Two Collected Cases of Insanity. American Journal of Insanity, Volume 56, Issue 2, lokakuu 1899: 257–273
https://ajp.psychiatryonline.org/doi/10.1176/ajp.56.2.257
Macalpine, Ida & Hunter, Richard (1969). George III and the Mad-Business. London: Allen Lane.
Mackay, Angus V. & Iversen, Leslie L. & Rossor, Martin & Spokes, Ernest & Bird, Edward. & Arregui, Alberto & Creese, Ian & Snyder, Solomon H. (1982). Increased brain dopamine and dopamine receptors in schizophrenia. Archives of general psychiatry, 39(9), syyskuu 1982: 991–997
https://doi.org/10.1001/archpsyc.1982.04290090001001
https://pubmed.ncbi.nlm.nih.gov/7115016/
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/492863
Madness Network News
https://madnessnetworknews.com/archives-original/
Madsen, A. & Keidling, N. & Karle, A. & Esbjerg, S. & Hemmingsen, R. (1998). Neuroleptics in progressive structural brain abnormalities in psychiatric illness. Lancet (London, England), Volume 352, Issue 9130, syyskuu 1998: 784–785
https://doi.org/10.1016/s0140-6736(05)60678-2
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)60678-2/abstract
https://pubmed.ncbi.nlm.nih.gov/9737286/
Maine, Harold (1947). If a Man Be Mad. New York: Doubleday.
Maisel, Albert Q. (1946). ’Bedlam 1946’. Life Magazine 6.5.1946.
https://books.google.fi/books?id=BlUEAAAAMBAJ&pg=PA102&dq=life+magazine+1946+bedlam&ei=c...
https://mn.gov/mnddc/parallels2/prologue/6a-bedlam/bedlam-life1946.pdf
https://mn.gov/mnddc/parallels2/prologue/6a-bedlam/6a-bedlam.html
Malhotra, Anil K. & Pinals, Debra A. & Adler, Caleb M. & Elman, Igor & Clifton, Allan & Pickar, David & Breier, Alan (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 17(3), syyskuu 1997: 141–150
https://doi.org/10.1016/S0893-133X(97)00036-5
https://pubmed.ncbi.nlm.nih.gov/9272481/
https://www.nature.com/articles/1395017
O’Malley, Mary (1914). Psychoses in the Colored Race. The American Journal of Insanity, Volume 71, Issue 2, 1914: 309–337
https://archive.org/details/sim_american-journal-of-psychiatry_1914-10_71_2/page/308/mode/2up
Malzberg, Benjamin (1938). Outcome of Insulin Treatment of One Thousand Patients with Dementia Praecox. Psychiatric Quarterly, Volume 12, syyskuu 1938: 528–553
https://link.springer.com/article/10.1007/BF01562947
Marder, Stephen R. & Davis, John M., & Chouinard, Guy (1997). The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. The Journal of clinical psychiatry, 58(12), joulukuu 1997: 538–546
https://doi.org/10.4088/jcp.v58n1205
https://pubmed.ncbi.nlm.nih.gov/9448657/
https://www.psychiatrist.com/jcp/effects-risperidone-five-dimensions-schizophrenia/
Marder, S. R. & Meibach, R. C. (1994). Risperidone in the treatment of schizophrenia. The American journal of psychiatry, Volume 151, Issue 6, kesäkuu 1994: 825–835
https://doi.org/10.1176/ajp.151.6.825
https://pubmed.ncbi.nlm.nih.gov/7514366/
https://psychiatryonline.org/doi/abs/10.1176/ajp.151.6.825
Mark, Tami L. & Levit, Katharine R. & Buck, Jeffrey A. & Coffey, Rosanna M. & Vandivort-Warren, Rita (2007). Mental health treatment expenditure trends, 1986-2003. Psychiatric services (Washington, D.C.), Volume 58, Number 8, elokuu 2007: 1041–1048
https://doi.org/10.1176/ps.2007.58.8.1041
https://pubmed.ncbi.nlm.nih.gov/17664514/
https://psychiatryonline.org/doi/10.1176/ps.2007.58.8.1041
Marlow, K. (2002). ’A Harsh Look at the Follies of Psychiatry’. Seattle Times, 1. helmikuuta 2002.
Mattes, Jeffrey A. (1997). Risperidone: how good is the evidence for efficacy?. Schizophrenia bulletin, Volume 23, Issue 1, 1. tammikuuta 1997: 155–161
https://doi.org/10.1093/schbul/23.1.155
https://pubmed.ncbi.nlm.nih.gov/9050121/
https://academic.oup.com/schizophreniabulletin/article/23/1/155/1880598
Matthews, Susan M. & Roper, Margaret T. & Mosher, Loren R., & Menn, Alma Z. (1979). A non-neuroleptic treatment for schizophrenia: analysis of the two-year postdischarge risk of relapse. Schizophrenia bulletin, Volume 5, No. 2, 1979: 322–333
https://doi.org/10.1093/schbul/5.2.322
https://pubmed.ncbi.nlm.nih.gov/37598/
https://psychrights.org/research/digest/chronicity/noneuroleptic.pdf
Maudsley, Henry (1867). The Physiology and Pathology of Mind. New York: D. Appleton & Company.
Maudsley, Henry (1879). The Pathology of Mind. London & New York: Macmillan and Co.
Maudsley, Henry (1895). The Pathology of Mind. London & New York: Macmillan and Co.
https://iiif.wellcomecollection.org/pdf/b21014115
https://wellcomecollection.org/works/qjannfrc
Medawar, Peter & Medawar, Jean (Editor) (1983). Aristotle to Zoos: A Philosophical Dictionary of Biology. Cambridge: Harvard University Press.
https://archive.org/details/aristotletozoosp0000meda_a0f0/page/n3/mode/2up
von Meduna, Ladislaus (1938). General Discussion of the Cardiazol Therapy. American Journal of Psychiatry, Volume 94, Issue 6S, elokuu 1938: 40–50
https://doi.org/10.1176/ajp.94.6S.40
https://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.94.6S.40?download=true&journalCode=ajp
Mehler, Barry Alan (1988). A History of The American Eugenics Society, 1921–1940. Urbana-Champaign: University of Illinois Ph.D. Dissertation.
Menninger, William C. (1938). The Results with Metrazol as an Adjunct Therapy in Schizophrenia and Depressions. Bulletin of the Menninger Clinic, Volume 2, Issue 5, 1938: 129–141
https://archive.org/details/sim_bulletin-of-the-menninger-clinic_1938-09_2_5
Miami Herald, Miller, Carol Marbin (2001). Advocates Alarmed by Drugs Used for Kids Medicaid Children Under under 6 at Issue. The Miami Herald 7.5.2001
https://poundpuplegacy.org/document/135917
Mintz, Morton (1965). The Therapeutic Nightmare: A Report on the Roles of the United States Food and Drug Administration, the American Medical Association, Pharmaceutical Manufacturers, and Others in Connection with the Irrational and Massive Use of Prescription Drugs that May be Worthless, Injurious. Boston: Houghton Mifflin
https://archive.org/details/therapeuticnight0000mint
Mirowsky, John (1990). Subjective Boundaries and Combinations in Psychiatric Diagnoses. Journal of Mind and Behavior, Volume 11, No 3-4, 1990: 407–424
https://www.jstor.org/stable/43854100
Mixter, William Jason & Tillotson, Kenneth. J. & Wies, David (1940). Frontal Lobotomy in Two Patients with Agitated Depression: Therapeutic Evaluation and Further Reference to Function of the Frontal Lobes. Archives of Neurology and Psychiatry, Volume 44, Issue 1, heinäkuu 1940: 236–239
Modrow, John (1992). How to Become a Schizophrenic: The Case Against Biological Psychiatry. Everett: Apollyon Press
Moniz, Egas (1936). Essai d’un traitement chirurgical de certaines psychoses. Bulletin de l’Academie de Medecine, 115, G. Masson, Editeur, Libraire de l'Académie de médecine, 1936: 385–392
Moore, Matthew T. & Winkelman, Nathaniel W. (1951). Some experiences with transorbital leucotomy. A review of results in 110 cases. The American journal of psychiatry. Volume 107, Issue 11, toukokuu 1951: 801–807
https://doi.org/10.1176/ajp.107.11.801
https://ajp.psychiatryonline.org/doi/10.1176/ajp.107.11.801
https://pubmed.ncbi.nlm.nih.gov/14829602/
Morgan, Maria G. & Scully, Paul J. & Youssef, Hanafy A. & Kinsella, Anthony & Owens, John M. & Waddington, John L. (2003). Prospective analysis of premature mortality in schizophrenia in relation to health service engagement: a 7.5-year study within an epidemiologically complete, homogeneous population in rural Ireland. Psychiatry research, 117(2), 127–135
https://doi.org/10.1016/s0165-1781(03)00002-7
https://pubmed.ncbi.nlm.nih.gov/12606015/
https://www.sciencedirect.com/science/article/abs/pii/S0165178103000027?via%3Dihub
Morton, Thomas G. The history of the Pennsylvania Hospital, 1751-1895. Philadelphia: Times Printing House, 1895. https://collections.nlm.nih.gov/catalog/nlm:nlmuid-68130800R-bk
https://digirepo.nlm.nih.gov/ext/dw/68130800R/PDF/681
https://ajp.psychiatryonline.org/doi/10.1176/ajp.53.3.445
Mosher, Loren & Bola, John R. (2000). The Soteria Project: Twenty-Five Years of Swimming Upriver. Complexity and Change 9, 2000: 68–73.
https://psychrights.org/research/Digest/Effective/upriver.pdf
Kts. Mosher, Loren & Bola, John R. (2002). The Soteria Project: Twenty Five Years of Swimming Upriver. Scrimali and Grimaldi (toim.) Cognitive Psychotherapy Toward a New Millennium. New York: Kluwer Academic/Plenum Publishers, pp, 247–254
https://link.springer.com/chapter/10.1007/978-1-4615-0567-9_40
Mosher, Loren R. & Menn, Alma Z. (1978). Community residential treatment for schizophrenia: two-year follow-up. Hospital & community psychiatry, 29(11), marraskuu 1978: 715–723
https://doi.org/10.1176/ps.29.11.715
https://pubmed.ncbi.nlm.nih.gov/700610/
https://psychiatryonline.org/doi/abs/10.1176/ps.29.11.715
Mosher, Loren R., Vallone, Robert & Menn, Alma (1995). The treatment of acute psychosis without neuroleptics: six-week psychopathology outcome data from The Soteria Project. The International journal of social psychiatry, 41(3), syyskuu 1995: 157–173
https://doi.org/10.1177/002076409504100301
https://pubmed.ncbi.nlm.nih.gov/8847197/
https://journals.sagepub.com/doi/10.1177/002076409504100301
Myerson, Abraham (1935). ’A Critique of Proposed ‘Ideal’ Sterilization Legislation’. Arch NeurPsych. 1935;33(3):453–466. doi:10.1001/archneurpsyc.1935.02250150003001
https://jamanetwork.com/journals/archneurpsyc/article-abstract/646436
Myerson, Abraham (1945). Borderline Cases Treated by Electric Shock. American Journal of Psychiatry, Volume 100, Issue 3, marraskuu 1943: 355–357
https://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.100.3.355?download=true&journalCode=ajp
Myerson, Abraham & Ayer, James & Putnam, Tracy J. & Keeler, Clyde E. & Alexander, Leo (1936). Eugenical sterilization: a reorientation of the problem. American Neurological Association. Committee for the Investigation of Eugenical Sterilization. New York: Macmillan.
https://wellcomecollection.org/works/czmt6n7s
https://psycnet.apa.org/record/1937-00296-000
Myslobodsky M. S. (1993). Central determinants of attention and mood disorder in tardive dyskinesia ("tardive dysmentia"). Brain and cognition, 23(1), syyskuu 1993: 88–101
https://doi.org/10.1006/brcg.1993.1047
https://www.sciencedirect.com/science/article/abs/pii/S027826268371047X
https://pubmed.ncbi.nlm.nih.gov/8217124/
Nathan, David L. (2002). Shedding Light – and Darkness. Barron’s, 4. maaliskuuta 2002. https://nathanmd.com/shedding-light-and-darkness/
Nation (1956). Drugs for the Mind. The Nation 21.7.1956
https://www.thenation.com/issue/
Neuropractice (2000), 7(6). Julkaisua ei löytynyt Google-haulla 24.7.2024.
New England Journal of Medicine Editorial (1934). Sterilization and Its Possible Accomplishment. New England Journal of Medicine VOL. 211 NO. 8 elokuu 1934: 379-380. DOI: 10.1056/NEJM193408232110813.
https://www.nejm.org/doi/abs/10.1056/NEJM193408232110813
New England Journal of Medicine (1936). Pääkirjoitus ’The Surgical Treatment of Certain Psychoses'. The New England Journal of Medicine, VOL. 215 NO. 23, 3. joulukuuta 1936): 1088. DOI: 10.1056/NEJM193612032152311
https://www.nejm.org/doi/full/10.1056/NEJM193612032152311
New England Journal of Medicine (1949). Pääkirjoitus 'Nobel Prize in Medicine'. The New England Journal of Medicine, Volume 241, No 25, 22. joulukuuta 1949: 1025-1026 DOI: 10.1056/NEJM194912222412508
https://www.nejm.org/doi/full/10.1056/NEJM194912222412508
New York Times (1921). Pääkirjoitus ’Eugenics as Romance’. New York Times 25.9.1921.
https://www.nytimes.com/1921/09/25/archives/eugenics-as-romance.html
New York Times (1921). ’Exhibited as Case for Merciful Extinction’. New York Times 7.2.1921. Artikkeli ei löytynyt Google-haulla 27.4.2024.
New York Times (1923). Pääkirjoitus ’His Trust in Eugenics Is Excessive’. New York Times 19. kesäkuuta 1923. Artikkeli ei löytynyt Google-haulla 21.4.2024.
New York Times (1933). Pääkirjoitus ‘Purifying the German Race’. New York Times 8. elokuuta 1933.
https://www.nytimes.com/1933/08/08/archives/purifying-the-german-race.html
New York Times (1936). FIND NEW SURGERY AIDS MENTAL CASES; Drs. Freeman and Watts Say Operation on Brain Has Eased Abnormal Worry. 6 SELECTED PATIENTS GAIN No Data Yet Available on Permanent Effects, Scientists Tell Southern Medical Group. New York Times 21. marraskuuta 1936
https://timesmachine.nytimes.com/timesmachine/1936/11/21/85436953.html
New York Times, Laurence, William L. (1937). Surgery Used on the Soul-Sick Relief of Obsessions Is Reported; New Brain Technique Is Said to Have Aided 65% of the Mentally Ill Persons on Whom It Was Tried as Last Resort, but Some Leading Neurologists Are Highly Skeptical of It. New York Times 7. kesäkuuta 1937
https://timesmachine.nytimes.com/timesmachine/1937/06/07/94384200.html
New York Times (1948). SURGERY RESTORES 'INCURABLY' INSANE; Revolutionary Brain Operation Called Topectomy Removes Tissues in Certain Areas. New York Times 19. maaliskuuta 1948
https://timesmachine.nytimes.com/timesmachine/1948/03/19/96421182.html
New York Times (1949). Pääkirjoitus ’Explorers of the Brain’. The New York Times 30. lokakuuta 1949
https://timesmachine.nytimes.com/timesmachine/1949/10/30/93331643.html
https://www.nytimes.com/1949/10/30/archives/explorers-of-the-brain.html
New York Times, Howard A. Rusk (1955). Aid for the Mentally Ill; A Report on the Effectiveness of Two New Drugs in Treating Certain Cases. The New York Times, 26.6.1955
New York Times, Eganspecial, Leo (1955). 2 Southerners Back Stevenson. The New York Times 13.8.1955
https://timesmachine.nytimes.com/timesmachine/1955/08/13/83780228.html
New York Times, Kaplan, Morris (1956). ANALYST HITS USE OF CALMING DRUGS; Zilboorg Tells Parley They Hinder Mental Therapy – Colleagues Disagree Drugs Widely Used. The New York Times 11.3.1956
https://timesmachine.nytimes.com/timesmachine/1956/03/11/96938713.html
New York Times (1956). Tranquilizer Drugs Are Held Harmful. The New York Times 19.12.1956
https://www.nytimes.com/1956/12/19/archives/tranquilizer-drugs-are-held-harmful.html
New York Times (1958). House Inquiry Opens on Tranquilizer Ads. The New York Times 12.2.1958
https://www.nytimes.com/1958/02/12/archives/house-inquiry-opens-on-tranquilizer-ads.html
https://timesmachine.nytimes.com/timesmachine/1958/02/12/89050034.html
New York Times (1958). Tranquilizer Study Told of Curb on Ads. The New York Times 13.2.1958
https://www.nytimes.com/1958/02/13/archives/tranquilizer-study-told-of-curb-on-ads.html
https://timesmachine.nytimes.com/timesmachine/1958/02/13/89051580.html
New York Times, Toth, Robert C. (1963). PRESIDENT SEEKS FUNDS TO REDUCE MENTAL ILLNESS; Asks Congress to Approve Plan to Stimulate State and Private Efforts URGES HEALTH CENTERS Limited Aid to Communities Would Cost $400,000,000 Over 4 or 5 Years Aim of New Program Fund for Mental Health Health Message Due KENNEDY ASKS AID FOR MENTALLY ILL Cites New Approach. The New York Times 6.2.1963
https://timesmachine.nytimes.com/timesmachine/1963/02/06/89517937.html
New York Times, Thorne, Ludmilla (1977). Inside Russia’s. The New York Times Magazine, 12. kesäkuuta 1977
https://www.nytimes.com/1977/06/12/archives/inside-russias-russian-prisons.html
New York Times, Castillo, Angel (1981). Mental Patients’ Right to Refuse Medication Is Contested in Jersey. The New York Times 28. maaliskuuta 1981
New York Times, Goleman, Daniel (1985). State Hospital Accused of Wrong Diagnoses, Fueling Debate over Nation’s Mental Care. The New York Times 23.4.1985
New York Times, Freudenheim, Milt (1992). Seeking Safer Treatments for Schizophrenia. The New York Times 15.1.1992
New York Times (1996). America’s Pharmaceutical Research Companies -mainos. New York Times 18.8.1996. Mainosta ei löytynyt Google-haulla 30.6.2024.
New York Times (1996). A New Drug for Schizophrenia Wins Approval From the F.D.A. The New York Times 2.10.1996
https://www.nytimes.com/1996/10/02/us/a-new-drug-for-schizophrenia-wins-approval-from-the-fda.html
New York Times, Bernstein, Nina (1999). From Early Promise To Violent Death; Central Park Killing Ends Effort To Save a Mentally Ill Woman. New York Times, 8. elokuuta 1999
New York Times, Dreifus, Claudia (2008). Using Imaging to Look at Changes in the Brain. The New York Times 15.9.2008
https://www.nytimes.com/2008/09/16/health/research/16conv.html